HEMOPOIETIC STEM CELL DIFFERENTIATION TO MACROPHAGES
HEMOPOIETIC STEM CELL DIFFERENTIATION TO MACROPHAGES
批准号:
2894542
负责人:
E. RICHARD STANLEY
金额:
$39.13万
依托单位国家:
美国
项目类别:
财政年份:
1982
资助国家:
美国
项目状态:
已结题
起止时间:
1982-02-01 至 2002-04-30
关键词:
autocrine cell differentiation clinical research colony stimulating factor gene induction /repression genetically modified animals growth factor receptors hematopoietic stem cells human subject laboratory mouse leukopoiesis macrophage protein biosynthesis radiation carcinogenesis radiation leukemia receptor expression
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (Adapted from investigator's abstract) Colony stimulating
factor-1 (CSF-1) regulates the survival, proliferation and differentiation
of mononuclear phagocytes and the function of other cells of the female
reproductive tract. It is either secreted as a glycoprotein or chondroitin
sulfate-containing proteoglycan, both of which are found in biologically
active concentrations in the circulation, or expressed in biologically
active form at the cell surface as a membrane spanning glycoprotein. The
cell surface CSF-1 and the proteoglycan CSF-1 can act in a localized
fashion, the former by direct cell-cell interaction with target cells or by
local proteolytic release of soluble growth factor from the cell surface,
and the proteoglycan CSF-1 by its sequestration to particular extracellular
matrices.
Studies with the osteopetrotic (csfm-op/csfm-op) mutant mouse, that
possesses an inactivating mutation in the CSF-1 gene, indicate that CSF-1 is
the primary regulator of mononuclear phagocyte production. They also
indicate that CSF-1, via its local and humoral action on target cells,
regulates many processes that are vital for the normal development and
function of a variety of non-hematopoietic tissues and organs, including
bone, brain, dermis and the reproductive organs. In addition, other studies
indicate that CSF-1 plays an important autocrine or paracrine role in
leukemias and in neoplasias of the female reproductive system.
The overall aim of this proposal is to further understand the biological
roles of CSF-1 and the CSF-1 receptor (CSF-1R). Answers will be sought to
the following questions: 1) Which cell types synthesize CSF-1 in vivo? How
is CSF-1 synthesis by these cell types regulated? 3) What forms of CSF-1
(secreted glycoprotein, proteoglycan or cell surface) regulate the various
CSF-1 target cells? 4) Are all of the effects of CSF-1 mediated via the
known CSF-1R (c-fms protooncogene product)? 5) Is this receptor regulated
by other ligands? 6) How is CSF-1 involved in the development of mouse
radiation-induced leukemias that exhibit autocrine regulation by CSF-1? The
specific aims are: 1.To identify the cells that synthesize CSF-1 in vivo.
2. To elucidate the regulation of CSF-1 gene expression. 3.To determine
the mechanism of regulation of the various CSF-1 responsive cells in
different tissues and to analyze their functions. 4.To disrupt the mouse
CSF-1R gene and analyze the phenotype of CSF-1R-null mice. 5. To elucidate
the role of CSF-1 in the development of radiation-induced leukemias of SJL/J
mice.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Analysis of a mouse model of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia.
-
批准号:9473903
-
项目类别:
-
资助金额:$2.37万
-
财政年份:2017
-
负责人:E. RICHARD STANLEY
-
依托单位:
Analysis of a mouse model of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia.
-
批准号:9136883
-
项目类别:
-
资助金额:$49.48万
-
财政年份:2015
-
负责人:E. RICHARD STANLEY
-
依托单位:
Analysis of a mouse model of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia.
-
批准号:9313335
-
项目类别:
-
资助金额:$49.48万
-
财政年份:2015
-
负责人:E. RICHARD STANLEY
-
依托单位:
Analysis of a mouse model of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia.
-
批准号:9028652
-
项目类别:
-
资助金额:$51.79万
-
财政年份:2015
-
负责人:E. RICHARD STANLEY
-
依托单位:
Analysis of a mouse model of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia.
-
批准号:9857702
-
项目类别:
-
资助金额:$18.61万
-
财政年份:2015
-
负责人:E. RICHARD STANLEY
-
依托单位:
CSF-1R Signaling Pathways Regulating macrophage chemotaxis and angiogenic fac rel
-
批准号:7534104
-
项目类别:
-
资助金额:$25.71万
-
财政年份:2008
-
负责人:E. RICHARD STANLEY
-
依托单位:
Macrophage Signaling Pathways Enhancing Tumor Progression
-
批准号:8669392
-
项目类别:
-
资助金额:$25.58万
-
财政年份:2003
-
负责人:E. RICHARD STANLEY
-
依托单位:
SHARK KINASE SIGNALING IN THE ECOTDERMAL EPITHELIUM
-
批准号:2023863
-
项目类别:
-
资助金额:$23.17万
-
财政年份:1997
-
负责人:E. RICHARD STANLEY
-
依托单位:
SHARK KINASE SIGNALING IN THE ECOTDERMAL EPITHELIUM
-
批准号:2634830
-
项目类别:
-
资助金额:$21.94万
-
财政年份:1997
-
负责人:E. RICHARD STANLEY
-
依托单位:
SHARK KINASE SIGNALING IN THE ECOTDERMAL EPITHELIUM
-
批准号:6138546
-
项目类别:
-
资助金额:$22.74万
-
财政年份:1997
-
负责人:E. RICHARD STANLEY
-
依托单位:
SHARK KINASE SIGNALING IN THE ECOTDERMAL EPITHELIUM
-
批准号:2857271
-
项目类别:
-
资助金额:$22.24万
-
财政年份:1997
-
负责人:E. RICHARD STANLEY
-
依托单位:
Hemopoietic Stem Cell Differentiation to Macrophages
-
批准号:6475366
-
项目类别:
-
资助金额:$43.58万
-
财政年份:1982
-
负责人:E. RICHARD STANLEY
-
依托单位:
Hemopoietic Stem Cell Differentiation to Macrophages
-
批准号:6624495
-
项目类别:
-
资助金额:$45.83万
-
财政年份:1982
-
负责人:E. RICHARD STANLEY
-
依托单位:
Hemopoietic Stem Cell Differentiation to Macrophages
-
批准号:6888904
-
项目类别:
-
资助金额:$46.7万
-
财政年份:1982
-
负责人:E. RICHARD STANLEY
-
依托单位:
HEMOPOIETIC STEM CELL DIFFERENTIATION TO MACROPHAGES
-
批准号:2088354
-
项目类别:
-
资助金额:$36.74万
-
财政年份:1982
-
负责人:E. RICHARD STANLEY
-
依托单位:
HEMOPOIETIC STEM CELL DIFFERENTIATION TO MACROPHAGES
-
批准号:3170434
-
项目类别:
-
资助金额:$24.21万
-
财政年份:1982
-
负责人:E. RICHARD STANLEY
-
依托单位:
HEMOPOIETIC STEM CELL DIFFERENTIATION TO MACROPHAGES
-
批准号:6375647
-
项目类别:
-
资助金额:$40.86万
-
财政年份:1982
-
负责人:E. RICHARD STANLEY
-
依托单位:
HEMOPOIETIC STEM CELL DIFFERENTIATION TO MACROPHAGES
-
批准号:6172349
-
项目类别:
-
资助金额:$39.98万
-
财政年份:1982
-
负责人:E. RICHARD STANLEY
-
依托单位:
HEMOPOIETIC STEM CELL DIFFERENTIATION TO MACROPHAGES
-
批准号:2088355
-
项目类别:
-
资助金额:$39.14万
-
财政年份:1982
-
负责人:E. RICHARD STANLEY
-
依托单位:
HEMOPOIETIC STEM CELL DIFFERENTIATION TO MACROPHAGES
-
批准号:2088356
-
项目类别:
-
资助金额:$41.03万
-
财政年份:1982
-
负责人:E. RICHARD STANLEY
-
依托单位:
海外基金